MEDQUIST INC (MEDQ) [Rocket]

Overview

MEDQUIST INC (MEDQ)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
10/21/2011	EFFECT	Form EFFECT - Notice of Effectiveness
10/18/2011	POS AM	Form POS AM - Post-Effective amendments for registration statement
10/18/2011	POS AM	Form POS AM - Post-Effective amendments for registration statement
10/18/2011	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/18/2011	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/18/2011	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/18/2011	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-10	Dec-31-09	Dec-31-08	Dec-31-07	Dec-31-06	Dec-31-05	Dec-31-04	Dec-31-03
Revenues	375.2	307.2	326.9	340.3	358.1	353.0	451.9	484.8
Revenue growth	22.1%	-6.0%	-4.0%	-5.0%	1.4%	-21.9%	-6.8%
Cost of goods sold	249.6	206.3	230.4	260.9	280.3	315.4	336.2	348.4
Gross profit	125.7	100.9	96.5	79.5	77.8	37.6	115.7	136.3
Gross margin	33.5%	32.9%	29.5%	23.3%	21.7%	10.7%	25.6%	28.1%
Selling, general and administrative	37.1	33.4	47.5	62.3	53.7	54.6	46.4	43.7
Research and development	12.8	9.6	15.8	13.7	13.2	9.8	10.5	10.2
EBITA	43.2	26.1	-4.1	-13.6	-13.9	-85.7	29.9	63.7
EBITA margin	11.5%	8.5%	-1.3%	-4.0%	-3.9%	-24.3%	6.6%	13.1%
Amortization of intangibles				5.5	5.8	8.2	8.9	9.8
EBIT	43.2	26.1	-4.1	-19.1	-19.7	-93.9	21.0	54.0
EBIT margin	11.5%	8.5%	-1.3%	-5.6%	-5.5%	-26.6%	4.7%	11.1%
Pre-tax income	31.7	25.3	-85.3	-12.9	-14.6	-90.9	8.0	54.8
Income taxes	0.7	2.0	-16.5	2.3	2.3	20.8	4.2	19.2
Tax rate	2.1%	7.8%	19.4%				53.1%	35.1%
Net income	31.1	23.3	-68.8	-15.2	-16.9	-111.6	3.7	35.6
Net margin	8.3%	7.6%	-21.0%	-4.5%	-4.7%	-31.6%	0.8%	7.3%

Diluted EPS	$0.83	$0.62	($1.83)	($0.41)	($0.45)	($2.98)	$0.10	$0.94
Shares outstanding (diluted)	37.6	37.6	37.5	37.5	37.5	37.5	37.6	37.7

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.